Company intelligence / Profile preview

Red House Communications

Unknown, Unknown, United States

Ownership: Private
Development stage: Other

Overview

Red House Communications specializes in corporate and investor communications for emerging biotech and life sciences companies. They advise clients developing advanced health technologies such as gene circuits, directed evolution therapeutics, and mRNA-based approaches. Their work focuses on storytelling, media relations, investor value communication, patient advocacy engagement, and employee/internal communications[1][10]. There are also similarly named entities focused on general marketing or healthcare B2B marketing services. See "other_info" for clarification of multiple entities with similar names.

Industry: Consulting

Beyond the preview

Go deeper on Red House Communications.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Red House Communications.

Explore the full profile